Exabis Library
Welcome to the e-CCO Library!
P652 Underweight patients with Crohn’s disease and without vitamin D supplementation are at high risk of vitamin D deficiency
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P652: Compare risk factors associated with infectious complication in Crohn’s disease with and without preoperative infliximab
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P652: Nutritional adequacy of popular defined diets for inflammatory bowel disease
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P652: The burden of mental illness, including deliberate self-harm, before and after a diagnosis of IBD, a UK population study.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P652: Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response.
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P652: Treatment patterns in patients receiving outpatient care for inflammatory bowel disease in Russian Federation
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P652: Unmet needs of physicians managing inflammatory bowel disease. A Survey of the Italian Group for Inflammatory Bowel Disease (IG-IBD)
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P653 Efficacy and safety of an additional 8 weeks of tofacitinib induction therapy: Updated results of the OCTAVE Open study for tofacitinib 8-week induction non-responders
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P653: Impact of ileostomy on recurrence rate after ileo-colic resection for Crohn’s disease: A critical appraisal from a referral centre
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P653: Ligation of the intersphincteric fistula tract vs. endorectal advancement flap for high perianal fistulas in Crohn’s disease: a retrospective cohort study
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P653: Rheumatic extraintestinal manifestations in ulcerative colitis : Prevalence and predictive factors
2021
ECCO'21 Virtual
Wednesday, 2 June 2021, 4:12 PM
P653: The changing epidemiology of IBD in the western world: a population-based study from Denmark
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P653: The efficacy and safety of stem cell therapy for Crohn's disease: a meta-analysis
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM
P653: Tight control and Treat to target increase the rates of Transmural remission and Transmural response in Crohn's disease
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P654 Influence of the interval of time between anti-TNF and vedolizumab or ustekinumab in the response to treatment in patients with inflammatory bowel disease
2020
ECCO'20 Vienna
Thursday, 30 January 2020, 10:12 AM
P654: Advances in optimalisation of therapeutic drug monitoring using mucosal TNF expression and anti-TNF concentration in patients with inflammatory bowel disease treated with biologicals: Preliminary results from a single-centre study
2018
ECCO '18 Vienna
Thursday, 21 February 2019, 9:14 AM
P654: Clinical outcomes in familial versus sporadic inflammatory bowel disease diagnosed in the era of biological therapies. Prospective data from the ENEIDA registry.
2022
ECCO'22
Friday, 11 February 2022, 3:56 PM
P654: Controversies in the management of anti-TNF therapy in Crohn's disease patients. A Delphi consensus
2023
ECCO’23 Copenhagen
Friday, 14 July 2023, 11:12 AM
P654: Monitoring of drug concentrations to predict remission under ustekinumab induction therapy in Crohn's disease patients
2019
ECCO '19 Copenhagen
Friday, 22 February 2019, 9:41 AM
P654: Mucosal healing with a second anti-TNF-α in patients with ulcerative colitis after the failure of the previous anti-TNF-α treatment
2017
ECCO '17 Barcelona
Wednesday, 20 February 2019, 10:36 AM